Minjing Zou1, Ali S Alzahrani2, Ali Al-Odaib1, Mohammad A Alqahtani3, Omer Babiker4, Roua A Al-Rijjal1, Huda A BinEssa1, Walaa E Kattan1, Anwar F Al-Enezi1, Ali Al Qarni5, Manar S A Al-Faham1, Essa Y Baitei1, Afaf Alsagheir6, Brian F Meyer1, Yufei Shi1. 1. Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. 2. Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. 3. Department of Pediatrics, Aseer Central Hospital, Abha, Saudi Arabia. 4. Department of Medicine, King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Saudi Arabia. 5. Department of Pediatrics, King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Saudi Arabia. 6. Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Abstract
Context: Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder, affecting one in 3000 to 4000 newborns. Since the introduction of a newborn screening program in 1988, more than 300 cases have been identified. The underlying genetic defects have not been systematically studied. Objective: To identify the mutation spectrum of CH-causing genes. Methods: Fifty-five patients from 47 families were studied by next-generation exome sequencing. Results: Mutations were identified in 52.7% of patients (29 of 55) in the following 11 genes: TG, TPO, DUOX2, SLC26A4, SLC26A7, TSHB, TSHR, NKX2-1, PAX8, CDCA8, and HOXB3. Among 30 patients with thyroid dyshormonogenesis, biallelic TG mutations were found in 12 patients (40%), followed by biallelic mutations in TPO (6.7%), SLC26A7 (6.7%), and DUOX2 (3.3%). Monoallelic SLC26A4 mutations were found in two patients, one of them coexisting with two tandem biallelic deletions in SLC26A7. In 25 patients with thyroid dysgenesis, biallelic mutations in TSHR were found in six patients (24%). Biallelic mutations in TSHB, PAX 8, NKX2-1, or HOXB3 were found once in four different patients. A monoallelic CDCA8 mutation was found in one patient. Most mutations were novel, including three TG, two TSHR, and one each in DUOX2, TPO, SLC26A7, TSHB, NKX2-1, PAX8, CDCA8, and HOXB3. SLC26A7 and HOXB3 were novel genes associated with thyroid dyshormonogenesis and dysgenesis, respectively. Conclusions: TG and TSHR mutations are the most common genetic defects in Saudi patients with CH. The prevalence of other disease-causing mutations is low, reflecting the consanguineous nature of the population. SLC26A7 mutations appear to be associated with thyroid dyshormonogenesis.
Context:Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder, affecting one in 3000 to 4000 newborns. Since the introduction of a newborn screening program in 1988, more than 300 cases have been identified. The underlying genetic defects have not been systematically studied. Objective: To identify the mutation spectrum of CH-causing genes. Methods: Fifty-five patients from 47 families were studied by next-generation exome sequencing. Results: Mutations were identified in 52.7% of patients (29 of 55) in the following 11 genes: TG, TPO, DUOX2, SLC26A4, SLC26A7, TSHB, TSHR, NKX2-1, PAX8, CDCA8, and HOXB3. Among 30 patients with thyroid dyshormonogenesis, biallelic TG mutations were found in 12 patients (40%), followed by biallelic mutations in TPO (6.7%), SLC26A7 (6.7%), and DUOX2 (3.3%). Monoallelic SLC26A4 mutations were found in two patients, one of them coexisting with two tandem biallelic deletions in SLC26A7. In 25 patients with thyroid dysgenesis, biallelic mutations in TSHR were found in six patients (24%). Biallelic mutations in TSHB, PAX 8, NKX2-1, or HOXB3 were found once in four different patients. A monoallelic CDCA8 mutation was found in one patient. Most mutations were novel, including three TG, two TSHR, and one each in DUOX2, TPO, SLC26A7, TSHB, NKX2-1, PAX8, CDCA8, and HOXB3. SLC26A7 and HOXB3 were novel genes associated with thyroid dyshormonogenesis and dysgenesis, respectively. Conclusions: TG and TSHR mutations are the most common genetic defects in Saudi patients with CH. The prevalence of other disease-causing mutations is low, reflecting the consanguineous nature of the population. SLC26A7 mutations appear to be associated with thyroid dyshormonogenesis.
Authors: S Acar; S Gürsoy; G Arslan; Ö Nalbantoğlu; F Hazan; Ö Köprülü; B Özkaya; B Özkan Journal: J Endocrinol Invest Date: 2021-11-15 Impact factor: 4.256
Authors: Maricel F Molina; Patricia Papendieck; Gabriela Sobrero; Viviana A Balbi; Fiorella S Belforte; Elena Bueno Martínez; Ezequiela Adrover; María C Olcese; Ana Chiesa; Mirta B Miras; Verónica G González; Mauricio Gomes Pio; Rogelio González-Sarmiento; Héctor M Targovnik; Carina M Rivolta Journal: Endocrine Date: 2022-05-04 Impact factor: 3.925
Authors: Hakan Cangul; Xiao-Hui Liao; Erik Schoenmakers; Jukka Kero; Sharon Barone; Panudda Srichomkwun; Hideyuki Iwayama; Eva G Serra; Halil Saglam; Erdal Eren; Omer Tarim; Adeline K Nicholas; Ilona Zvetkova; Carl A Anderson; Fiona E Karet Frankl; Kristien Boelaert; Marja Ojaniemi; Jarmo Jääskeläinen; Konrad Patyra; Christoffer Löf; E Dillwyn Williams; Manoocher Soleimani; Timothy Barrett; Eamonn R Maher; V Krishna Chatterjee; Samuel Refetoff; Nadia Schoenmakers Journal: JCI Insight Date: 2018-10-18